Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30179321 | 0.82 | CYP2D6 (0.49) | CYP2D6KDM1AOPRM1 | |
| SCHEMBL23778300 | 0.82 | CYP2D6 (0.50) | CYP2D6KDM1AOPRM1KMT2A | |
| SCHEMBL23798654 | 0.81 | OPRL1 (0.56) | CYP2D6KDM1AOPRM1KMT2A | |
| SCHEMBL9435664 | 0.80 | OPRL1 (0.58) | CYP2D6KDM1AOPRM1 | |
| SCHEMBL20066074 | 0.78 | CYP2D6 (0.47) | CYP2D6KDM1AOPRM1KMT2A | |
| SCHEMBL504355 | 0.76 | OPRM1 (0.70) | OPRM1KMT2A | |
| SCHEMBL23778282 | 0.76 | CYP2D6 (0.53) | CYP2D6KDM1AOPRM1KMT2A | |
| SCHEMBL13654981 | 0.76 | OPRM1 (0.54) | CYP2D6KDM1AOPRM1 | |
| SCHEMBL9435475 | 0.75 | CYP2D6 (0.49) | CYP2D6KDM1AOPRM1KMT2A | |
| SCHEMBL6963361 | 0.75 | CYP2D6 (0.49) | CYP2D6KDM1AOPRM1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3526207-B1 | HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. | HEPTARES THERAPEUTICS LTD (GB) | 2021-09-08 | — | — | EP | disclosed |